General Capillary Endothelial Cells Undergo Reprogramming into Arterial Endothelial Cells in Pulmonary Hypertension through HIF-2α/Notch4 Pathway

Bin Liu,Dan Yi,Xiaomei Xia,Karina Ramirez,Hanqiu Zhao,Yanhong Cao,Ankit Tripathi,Ryan Dong,Anton Gao,Hongxu Ding,Shenfeng Qiu,Vladimir V. Kalinichenko,Michael B. Fallon,Zhiyu Dai
DOI: https://doi.org/10.1101/2024.02.13.580227
2024-03-10
Abstract:Pulmonary arterial hypertension (PAH) is characterized by a progressive increase of pulmonary vascular resistance and obliterative pulmonary vascular remodeling that result in right heart hypertrophy, failure, and premature death. The underlying mechanisms of loss of distal capillary endothelial cells (ECs) and obliterative vascular lesion formation remain unclear. Our recent single-cell RNA sequencing, spatial transcriptomics analysis, RNASCOPE, and immunostaining analysis showed that arterial ECs accumulation and loss of capillary ECs were evident in human PAH patients and pulmonary hypertension (PH) rodents. Pseudotime trajectory analysis of the single-cell RNA sequencing data suggest that lung capillary ECs transit to arterial ECs during the development of PH. Our study also identified CXCL12 as the marker for arterial ECs in PH. Capillary EC lineage tracing approach using capillary specific-Dre;Tdtomato reporter mice demonstrated that capillary ECs gave rise to arterial ECs during PH development. Genetic deletion of HIF-2a or pharmacological inhibition of Notch4 normalized the arterial programming in PH. In conclusion, our study demonstrates that capillary endothelium transits to arterial endothelium through the HIF-2a-Notch4 pathway during the development of PAH. Thus, targeting arterial EC transition might be a novel approach for treating PAH patients.
Physiology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the mechanism of distal capillary endothelial cell (ECs) loss and arterial endothelial cell accumulation in pulmonary arterial hypertension (PAH). Specifically, through methods such as single - cell RNA sequencing, spatial transcriptomics analysis, RNASCOPE, and immunostaining, the researchers explored how general capillary endothelial cells (gCap ECs) are reprogrammed into arterial endothelial cells (ArtECs) through the HIF - 2α/Notch4 signaling pathway during the development of pulmonary arterial hypertension. This process may lead to a decrease in capillary endothelial cells and an increase in arterial endothelial cells in the distal microvascular bed of the lungs in PAH patients, thereby affecting the progression of the disease. The ultimate goal of the study is to reveal this conversion mechanism and explore the possibility of inhibiting this abnormal conversion as a new strategy for treating PAH.